Valeant Pharmaceuticals names accounting chief

By 2016-07-10T21:15:00

Valeant Pharmaceuticals International disclosed in a Form 8-K that it has appointed Sam Eldessouky as chief accounting officer, effective as of June 15. He assumed this role from Robert Rosiello, who will continue to serve as senior vice president and chief financial officer.

THIS IS MEMBERS-ONLY CONTENT

SINGLE MEMBERSHIP                                             CORPORATE MEMBERSHIP

You are not logged in and do not have access to members-only content.

If you are already a registered user or a member, SIGN IN now.